The present invention relates to new compounds that show pharmacological activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels or dual activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels, and the µ-opiod receptor (MOR or mu-opioid). The invention is also related to the process for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments (formula (I)).
本发明涉及对电压门控
钙通道(VGCC)的亚单位α2δ,特别是对电压门控
钙通道的α2δ-1亚单位或对电压门控
钙通道(VGCC)的亚单位α2δ表现出药理活性的新化合物,特别是对电压门控
钙通道的α2δ-1亚单位,以及与µ-阿片受体(MOR或μ-阿片)具有双重活性。该发明还涉及所述化合物的制备方法,以及包含它们的组合物,以及它们作为药物的用途(公式(I))。